Patents Represented by Law Firm Office of Technology Transfer, NIH
  • Patent number: 5698593
    Abstract: Nodulocystic and conglobate acne in humans can be alleviated by the oral administration of 13-cis-retinoic acid or a derivative thereof. The active ingredient is administered in a dosage of from about 1.5 to about 3 mg/kg of body weight per day for a period of from about two to about four weeks.
    Type: Grant
    Filed: April 15, 1993
    Date of Patent: December 16, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Gary L. Peck
  • Patent number: 5183949
    Abstract: A rabbit model for testing anti-AIDS therapeutic agents, vaccines, and HIV-1 infection is described.
    Type: Grant
    Filed: March 15, 1989
    Date of Patent: February 2, 1993
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Thomas J. Kindt, Henrietta Kulaga, Thomas M. Folks